IMU 4.35% 4.8¢ imugene limited

Media Thread, page-15400

  1. 15,743 Posts.
    lightbulb Created with Sketch. 5765
    IMU PR machine in full swing ...

    Watch the replay of our investor webinar held yesterday. During the webinar, Imugene's Managing Director and CEO Leslie Chong, along with Chief Medical Officer Dr. Paul Woodard, discuss the latest data from the azer-cel Phase 1b clinical trial in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).


    Watch the full $IMU replay here: https://youtu.be/gAca4R3HCTc #Imugene #AzerCel #CancerResearch #CAR_T #DLBCL #Oncology #ClinicalTrials #InvestorWebinar #Biotech


    https://x.com/TeamImugene/status/1831462162604429594
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
0.002(4.35%)
Mkt cap ! $357.0M
Open High Low Value Volume
4.7¢ 4.9¢ 4.6¢ $977.7K 20.56M

Buyers (Bids)

No. Vol. Price($)
13 3232340 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 854027 4
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.